Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Sanacora

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
Focus (American Psychiatric Publishing)|January 25, 2020
Ketamine: A Review for CliniciansGerard Sanacora, Rachel Katz
Biological Psychiatry Global Open Science|December 23, 2024
The Role of Awe and Other Psychological Factors in Ketamine's Mechanism of Antidepressant ActionMina Ansari, Gerard Sanacora
Pharmacology, Biochemistry, and Behavior|November 24, 2011
The roles of glutamate receptors across major neurological and psychiatric disordersSteve Siegel, Gerard Sanacora
CNS Drugs|September 7, 2021
Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide RiskSina Nikayin, Gerard Sanacora
CNS Spectrums|January 10, 2006
Beyond monoamines: glutamatergic function in mood disordersAkira Kugaya, Gerard Sanacora
The Mount Sinai Journal of Medicine, New York|August 16, 2008
Major depression: emerging therapeuticsSrijan Sen, Gerard Sanacora
CNS & Neurological Disorders Drug Targets|April 14, 2007
GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant actionGerard Sanacora, Aybala Saricicek
Biological Psychiatry|June 4, 2013
From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disordersGerard Sanacora, Mounira Banasr
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 27, 2014
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?Gerard Sanacora, Alan F Schatzberg
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 9, 2014
Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addictionRobert E McCullumsmith, Gerard Sanacora
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Focus (American Psychiatric Publishing)|January 25, 2020
Ketamine: A Review for CliniciansGerard Sanacora, Rachel Katz
Biological Psychiatry Global Open Science|December 23, 2024
The Role of Awe and Other Psychological Factors in Ketamine's Mechanism of Antidepressant ActionMina Ansari, Gerard Sanacora
Pharmacology, Biochemistry, and Behavior|November 24, 2011
The roles of glutamate receptors across major neurological and psychiatric disordersSteve Siegel, Gerard Sanacora
CNS Drugs|September 7, 2021
Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide RiskSina Nikayin, Gerard Sanacora
CNS Spectrums|January 10, 2006
Beyond monoamines: glutamatergic function in mood disordersAkira Kugaya, Gerard Sanacora
The Mount Sinai Journal of Medicine, New York|August 16, 2008
Major depression: emerging therapeuticsSrijan Sen, Gerard Sanacora
CNS & Neurological Disorders Drug Targets|April 14, 2007
GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant actionGerard Sanacora, Aybala Saricicek
Biological Psychiatry|June 4, 2013
From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disordersGerard Sanacora, Mounira Banasr
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 27, 2014
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?Gerard Sanacora, Alan F Schatzberg
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 9, 2014
Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addictionRobert E McCullumsmith, Gerard Sanacora
Pageof 20